Back

Vanta Bioscience Ltd

IPO Details · GMP · Subscription · Financials

✅ Listed BSE SME SME Live Chart
Issue Price
₹50
Per Share
GMP
NIL
Grey Market
Est. Listing
₹50
Expected Price
Min. Application
₹300,000
2 lots × 3000 shares
IPO Issue Details
Issue Price / Price Band₹50 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size3,000 Shares per Lot
Total Issue Size15,12,000 shares (aggregating up to ₹7.56 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenMon, 25 Sep 2017
Subscription CloseWed, 27 Sep 2017
Anchor AllotmentSun, 24 Sep 2017
Basis of AllotmentTue, 03 Oct 2017
Initiation of RefundsWed, 04 Oct 2017
Credit of Shares to DematWed, 04 Oct 2017
Listing DateFri, 06 Oct 2017
UPI Mandate Deadline2017-09-27
Application & Investment Details
Retail — Min (1 Lots)150000 — 3000 shares
Retail — Max (13 Lots)₹1,950,000 (13 Lots)
HNI — Min (2 Lots)300000 — 6000 shares
Net Offer to Public14,34,000 shares (aggregating up to ₹7.17 Cr)
Reserved for Market Maker78,000 shares (aggregating up to ₹0.3900 Cr)
Pre-IPO Promoter Holding42,16,000 shares
Post-IPO Promoter Holding57,28,000 shares
About Vanta Bioscience Ltd

Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.

Objects of the Issue

Vanta Bioscience Ltd proposes to utilise the net proceeds from the Issue for the following objects:

1
Augmenting additional working capital requirements
6.79
2
General Corporate Purposes
0.27
Shareholding & Lock-in
Pre-IPO Promoter Holding 42,16,000 shares
Post-IPO Promoter Holding 57,28,000 shares
NSE Listing LinkView on NSE →
Check AllotmentCheck Status →
Vanta Bioscience Ltd — Live Price LIVE
₹50.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Vanta Bioscience Ltd is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹50.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹50
GMPNIL
Est. Listing₹50
Lot Size3,000 shares
Min Amount₹300,000
Listing Date06 Oct 2017
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹50
Listing Date06 Oct 2017
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
Market Maker 78,000 ₹0.39 Cr
TOTAL 1,512,000 100.00% ₹7.56 Cr
* Based on ₹50.00 (upper price band)
Lot Size & Investment Details
Lot Size
3,000
Shares
Issue Price
₹50.00
Per Share
Min Investment
₹150,000
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 3,000 ₹150,000
Retail (Max) 13 39,000 ₹1,950,000
sNII (Min) 14 42,000 ₹2,100,000
bNII (Min) 68 204,000 ₹10,200,000
Company Financials — Restated Consolidated (Amount in ₹ Lakhs)
Particulars31-Mar-2017FY 2023-24FY 2022-23
Revenue from Operations N/A N/A N/A
EBITDA N/A N/A N/A
Profit After Tax (PAT) N/A N/A N/A
Net Worth N/A N/A N/A
Total Assets 1374.59 N/A N/A
Reserves & Surplus 364.60 N/A N/A
Total Borrowings 750.54 N/A N/A
Financial data will be published once the company files its DRHP/RHP with SEBI.
Key Ratios & Valuation
Issue Price ₹50
Face Value ₹10 Per Share
P/BV N/A
RoE N/A
RoCE N/A
RoNW N/A
PAT Margin (%) N/A
EBITDA Margin (%) N/A
Debt / Equity N/A
Company Details
Company
Vanta Bioscience Ltd
Exchange
BSE SME
IPO Type
SME IPO
Issue Type
Fixed Price IPO
Face Value
₹10 Per Share
Script Code
N/A
Address
NO 02/G/308/G, NO 3/FF/SF/1-20-248 Umajay Complex, Rasoolpura, Secunderabad, Hyderabad, Telangana, 500003
Book Running Lead Managers
INVENTURE MERCHANT BANKER SERVICES PRIVATE LIMITED
Book Running Lead Manager (BRLM)